The associate professor of neurology at Icahn School of Medicine at Mount Sinai discussed the clinical and scientific advantages of blood-based biomarkers over imaging for Alzheimer disease. [WATCH TIME: 5 minutes]
Fanny Elahi, MD, PhD
Advertisement
Associate professor of neurology at Icahn School of Medicine at Mount Sinai.
Articles by Fanny Elahi, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Alexander Gold, MD, on Adrabetadex’s Impact in Infantile-Onset Niemann-Pick C
2
Showcasing Sustained Benefits in Myasthenia Gravis Research at AANEM 2025: Kimberly Moran, PhD, MBA
3
NeurologyLive® Brain Games: November 2, 2025
4
Designing the Phase 3 EMPEROR Trial and Future Considerations
5
